AIm: To assess the incidence, hormonal activity and postoperative follow up of the cases that are histopathologically diagnosed as atypical pituitary adenoma (APA) in our series. 
InTRoduCTIon
Pituitary adenomas comprise 15% of all intracranial tumors and are third in prevalence after gliomas and meningiomas (15) . Twenty percent of these pituitary adenomas are diagnosed incidentally and 27% are discovered in post mortem examination (2, 4) . The majority of pituitary adenomas consist of a benign phenotype that are slow growing and do not invade local tissues (1) . A small subset of pituitary adenomas, having a more aggressive behavior, invades to bone, vascular and neural tissues or cavernous sinus, and has the potential to grow at a faster rate (10) . This group of pituitary adenomas is not malignant, although, it displays aggressive phenotypes that have increased rates of recurrence despite surgical and radiation therapy. For this reason they are described as being atypical (1) . Either pre-operatively through radiological findings or during the course of surgery some adenomas will show invasion of adjacent structures. These adenomas are characterized as being invasive pituitary adenomas and a small subset is referred to as atypical pituitary adenomas (5) .
According to new classification criteria for endocrine tumors, released in 2004 by WHO, pituitary tumors are classified as benign adenomas, atypical adenomas, or carcinomas (3). Based on these classifications, the diagnostic criteria for atypical adenomas include: high mitotic activity, excessive p53 immunoreactivity, and a Ki-67 proliferative index above 3% (3) . The WHO's diagnostic classification has been a source of inspiration for various studies in the literature as well as a source of controversy (6, 7, 8, 9, 11, 12, 17) , but regardless, a number of studies have been published using these criteria to study the incidence and histopathology of atypical pituitary adenomas (13, 14, 15) .
Atypical pituitary adenomas exhibit aggressive clinical progression and highly invasive manifestations. For this reason, it is important to note that APAs have the capacity to cause a high degree of pathology in normal tissue as well as increased neurological deficits and difficulty of recession in surgical removal. It is also important to note that due to the rapidly dividing nature of atypical pituitary adenomas, higher than normal tumor growth, early post-operative recurrence is likely.
The goals of this study are to assess incidence rates, recurrence rates, and post-operative follow up of atypical pituitary adenomas.
MATeRIAl and MeThodS
Thirteen atypical pituitary adenoma cases among 146 patients harbouring pituitary adenomas operated via endoscopic endonasal transsphenoidal approach at Ankara Numune Education and Research Hospital Neurological Surgery Clinic between October 2009 and May 2012 were included in this study.
One hundred and forty-six patients who underwent surgery for pituitary adenomas were retrospectively reviewed and 13 cases diagnosed as having atypical pituitary adenomas according to WHO classification of CNS tumors (increased mitotic activity, Ki-67 proliferation index greater than 3%, and p53 gene immunoreactivity) were selected for the study. In these patients assessment included preoperative radiological records, preoperative hormone levels, history of previous pituitary operations, preoperative invasiveness parameters, post-operative radiological records, additional post-operative treatment, and post-operative recurrences. The patients who had Ki-67 indices above 3%, but did not present with increased mitotic activity were not included in the study.
Immunohistological studies were performed on formalinfixed and paraffin-embedded sections for the presence of ACTH, PRL, GH, TSH, FSH, LH, p53 and Ki-67. ACTH (AH 26, Thermo), FSH (N1539, Dako), GH (A0570, Dako), LH (LH01, Neomarkers), PRL (PRL02, Neomarkers), TSH (0042, Dako) Ki67 (MIB-1, Dako), and p53 (DO7, Dako) were identified with primary antibodies. In order to evaluate the positive Ki-67 cells, the sections with the highest antibody counts were magnified at 400x under light microscope, and 1000 nuclear stained cells were counted. The percentage of Ki-67 positive cells was calculated (Figure 1 A,B).
ReSulTS
Of the 146 pituitary adenoma patients who underwent endoscopic endonasal transsphenoidal surgery, 133 patients (91.1%) were classified as having typical adenomas and 13 (8.9%) as having atypical adenomas. Of the 13 patients with atypical adenomas, 10 (76.9) were male and 3 were female (23.1%). The age range of the patients was between 27 and 80 years (mean 52.7 years). Among 9 non-secretory adenomas (69.3%), 3 were prolactinoma (23.1%), and 1 was a somatostatinoma (7.6%). Of these 13 patients, 4 were radiologically and pre-operatively diagnosed as asymptomatic pituitary apoplexy (30.7%). Of the 4 patients with pituitary apoplexy, all were male, 2 had prolactinoma, and 2 had non-secretory adenoma (Figure 2 A,B).
All 13 of the atypical pituitary adenomas were macroadenoma (diameter greater than 1 cm). The pre-operative radiological images and macroscopic images of all 13 patients showed infiltration of the tumor into surrounding normal tissues (Figure 3 A-D) . All Ki-67 indexes of masses were assessed and found to be at 3-10% with a mean value of 4.7%.
In 16 of the 146 patients (10.95%), pituitary adenomas showed recurrence within an average time of 41 months. Of the patients that experienced tumor recurrence, 11 were typical adenomas (11/133, 8.2%) and 5 were atypical adenomas (5/13, 38.4%). The typical adenomas consisted of 4 somatotropinomas (36.3%), 3 ACTHomas (27.3%), 2 prolactinomas (18.2%), and 2 non-secretory adenomas. All recurrent atypical adenomas were non-secretory. Asymptomatic pituitary apoplexy existed in 4 of the 13 atypical adenoma patients (4/13). Two of the 4 apoplexy patients were prolactinomas, whereas the other 2 patients had non-secretory adenomas (Table I ).
All patients, returned with recurrent pituitary adenomas, again underwent an endoscopic endonasal transsphenoidal operation for maximum resection of the tumor.
dISCuSSIon
The aim of the present study is to investigate incidence rates, hormone profiles and recurrence rates of atypical pituitary adenomas which are diagnosed according to the criteria of the latest WHO endocrine tumors classification, and to discuss the follow up of these tumors. The incidence of atypical adenomas in 146 patients, who underwent endoscopic endonasal transsphenoidal surgery for pituitary adenomas, was 8.9%. Among 13 patients with atypical adenomas, 9 were non-secretory adenoma, 3 were prolactinoma and 1 was a somatostatinoma. All of these tumors were infiltrating macroadenomas. Ki-67 index ranged between 3-10% with a 
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widespread positive p53 protein expression, and increased mitotic activity (3). Each of these atypical criteria separately display more aggressive and invasive character of the lesion but the effect on recurrence and surrounding tissue invasion of all these tree criteria is still not collectively investigated (18 (10) . Previously, this group of pituitary adenomas with more aggressive phenotypes and higher rates of recurrence was differentiated as being aggressive or premalignant adenomas (18) . In the past, the functional behavior of typical and atypical adenomas were regarded as being similar in their recurrence rates, age of onset, and hormonal manifestations, with the most prominent difference was identified by MRI regarding invasion of the tumor (83% in atypical and 45% in typical adenomas) (18) .
Ki-67 is an antigen which is routinely examined in all pituitary adenoma specimens besides immunohistochemical staining. Increasing levels of this antigen is correlated with the speed of tumor growth, invasion of the tumor and tumor recurrence (18) . In 1996, the study of Thapar et al. revealed that the 3% or more increase of Ki-67 index is significant for differentiating invasive or noninvasive pituitary adenomas and this threshold level is accepted by the WHO (16) . In 2004, the WHO published a new classification scheme for the identification of atypical pituitary adenomas: Ki-67 index greater than 3%, non-secretory adenomas. These 5 patients with atypical pituitary adenoma had suprasellar and parasellar invasion, which were excised subtotally. These cases were all found to have residual tumor formation at their one-year follow up and were all treated again with endoscopic endonasal transsphenoidal surgery.
In our study, 7 of 146 pituitary adenoma patients exhibited asymptomatic pituitary apoplexy (4.7%), with 4 being atypical adenomas (2.7%). These four patients were male, with 2 having prolactinomas (1.3%) and the other two having non-secretory adenomas (1.3%).
In conclusion, our study sought to display all hormonal activities and recurrence patterns of atypical pituitary adenomas amongst total pituitary adenomas. Atypical pituitary adenomas are not as uncommon as once thought.
adenomas, that invade suprasellar and parasellar region, were macroadenomas. Of these patients, 9 had non-secretory adenoma (69.3%) and 4 had hormone secreting adenoma (30.7%). Of the four hormone secreting ones, 3 were classified as prolactinoma (23.1%) and 1 was classified as a somatotropinoma (7.6%).
In While the total resection of these masses is difficult, high mitotic activity also contributes to their high rates of recurrence. For this reason, these masses should be carefully followed post-operatively and additional treatment should be provided to prolong recurrence time. Additionally, with increased mitotic capacity of the tumors, these patients exhibit bleeding within their tumors and increased rates of pituitary apoplexy. Additional studies in greater numbers of patients will be necessary to supplement the body of knowledge that is present.
